Cartesian Therapeutics, Inc. (RNAC)
8.53
+0.08
(+0.95%)
USD |
NASDAQ |
Dec 12, 16:00
8.53
0.00 (0.00%)
After-Hours: 18:04
Cartesian Therapeutics Research and Development Expense (TTM): 54.74M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Repligen Corp. | 51.77M |
| Cabaletta Bio, Inc. | 132.01M |
| Arcellx, Inc. | 168.16M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |